News

NIH announced the final winners of a 2-year prize competition that encouraged community-based organizations to develop the infrastructure and capabilities to conduct maternal health research.

Umbilical cord milking, a technique to move blood from the umbilical cord to an infant’s body, does not increase the risk for neurodevelopmental disabilities in non-vigorous term infants—those who are limp, pale and with minimal breathing. The technique provides an alternative for delayed cord clamping for when resuscitation efforts are needed as soon as possible.

An AI program has the potential to identify signs of childbirth related post-traumatic stress disorder by evaluating short narratives of patients who have given birth. With further refinements, the program could potentially identify a large proportion of those at risk.

NIH has announced finalists in its competition to accelerate the development of diagnostic and monitoring technologies to improve fetal health outcomes.

Sepsis screening tools designed to account for the physiological changes that may occur during pregnancy perform best from 20 weeks of pregnancy through 3 days postpartum, research suggests. In early pregnancy and later in the postpartum period, tools based on general sepsis screening criteria may more accurately predict which patients are at high risk for maternal sepsis, a leading cause of pregnancy-related deaths.

An atlas of the placenta developed by NIH researchers offers insight on the communication that occurs between maternal and fetal cells during labor and delivery.

A questionnaire detecting strong emotional responses to traumatic births could help identify new mothers at risk for developing childbirth-related post-traumatic stress disorder. It may lead to faster diagnosis—and treatment—of post traumatic stress disorder in new mothers.

In 2023, NICHD continued its commitment to research to understand human development, improve reproductive health, promote women’s health, enhance the lives of children and adolescents, and optimize abilities for all. Highlights include steps toward reducing the global burden of maternal sepsis and establishing a standard treatment for opioid-exposed newborns.

As we ring in 2024, we’d like to take a brief look back on our accomplishments during 2023. These activities illustrate the institute’s continued commitment to research and training in its mission areas.

An early study suggests that a questionnaire can detect posttraumatic stress disorder (PTSD) after childbirth with high probability. If large-scale studies verify its effectiveness, the questionnaire could provide a rapid and efficient method for postnatal PTSD screening, allowing timely referral for a thorough assessment and treatment.

This collaboration will promote safe infant sleep with and within American Indian and Alaska Native communities.

NIH will award up to $2 million in cash prizes as part of its Fetal Monitoring Challenge to accelerate development of diagnostic and monitoring technologies that improve fetal health outcomes in low-resource settings. U.S. scientists, engineers, and clinicians can submit innovative approaches and compete for prizes and resources to support technology development and clinical impact, with a focus on point-of-care and home-based diagnostic and monitoring technologies that may reduce fetal health risk and loss during and after birth.

NIH has awarded $24 million in first-year funding to establish Maternal Health Research Centers of Excellence. The centers will develop and evaluate innovative approaches to reduce pregnancy-related complications and deaths and promote maternal health equity.

A device known as a pessary, thought promising for reducing preterm birth risk due to a short cervix, appears no more effective than usual medical care, according to a study funded by the National Institutes of Health. A pessary is a rounded silicone device that fits around a cervix that has shortened, to keep it from opening and leading to miscarriage or preterm birth. The device is typically removed before the 37th week of pregnancy.

Depression from six weeks gestation through the end of pregnancy may increase the risk of heart and blood vessel disease up to two years after birth, suggests an analysis funded by the National Institutes of Health.

A new guide developed by NICHD and its partners promises to standardize the exchange of clinical data on maternal and infant health. The guide is an important step toward establishing a common framework to help clinicians and scientists better understand the root causes and high rates of maternal morbidity and mortality.

NIH has announced the next round of winners of its Connecting the Community for Maternal Health Challenge—a $3 million prize competition to encourage community-based and advocacy organizations in the United States to develop the infrastructure and capabilities necessary to conduct maternal health research.

Researchers have found the “Eat, Sleep, Console” (ESC) care approach to be more effective than using the Finnegan Neonatal Abstinence Scoring Tool (FNAST) to assess and manage opioid-exposed newborns, according to a national clinical trial funded by the National Institutes of Health.

Tranexamic acid appears no more effective than placebo in reducing the need for blood transfusion or preventing maternal death in patients with increased risk for excessive bleeding because of cesarean delivery, according to a study funded by the National Institutes of Health. Tranexamic acid slows the natural breakdown of blood clots and was considered promising for reducing the risk of excessive bleeding after giving birth—known as postpartum hemorrhage—after cesarean delivery.

The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) has announced new funding for participating centers in its Maternal-Fetal Medicine Units (MFMU) Network.